Variability in Total Cholesterol, LDL Cholesterol Linked to Dementia
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 3, 2025 -- Variability in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) is associated with dementia and cognitive impairment, according to a study published online Jan. 27 in Neurology.
Zhen Zhou, Ph.D., from Monash University in Melbourne, Australia, and colleagues examined the association between year-to-year intraindividual lipid variability and the subsequent risk for cognitive decline and dementia in community-dwelling older adults in the ASPirin in Reducing Events in the Elderly randomized trial of aspirin. This post-hoc analysis included participants with lipid levels measured at baseline and in years 1, 2, and 3 and quantified year-to-year variability in TC, LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides.
The analysis included 9,846 individuals. The researchers identified 509 incident dementia events and 1,790 cognitive impairment with no dementia (CIND) events during a median follow-up of 5.8 and 5.4 years after assessment of variability. Comparing the highest and lowest quartiles of TC and LDL-C variability, respectively, the hazard ratios were 1.60 and 1.48 for dementia and 1.23 and 1.27 for CIND. Associations were also seen for higher TC and LDL-C variability with faster decline in global cognition, episodic memory, psychomotor speed, and the composite score for changes in four cognitive function domains. There was no strong evidence for an association of HDL-C and triglyceride variability with dementia and cognitive change.
"These results suggest that fluctuating cholesterol, measured annually, may be a new biomarker for identifying people at risk of dementia, providing more information than the actual cholesterol levels measured at a single time point," Zhou said in a statement.
Several authors disclosed ties to the biopharmaceutical industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 -- Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back...
Avoidable All-Cause Hospitalization, ED Visits Common in Nursing Homes
MONDAY, Aug. 4, 2025 -- Among severely impaired and terminally ill nursing home (NH) residents, all-cause hospitalizations (ACH) and emergency department visits without...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.